How does cannabis compare to NSAIDs for ankylosing spondylitis? 

When evaluating cannabis vs NSAIDs for ankylosing spondylitis, the conversation often centres on symptom relief, side effects, and long-term outcomes. NSAIDs are usually the first line of defence, offering anti-inflammatory benefits and quick pain reduction. Cannabis, meanwhile, is gaining attention as an alternative treatment with broader effects, including support for sleep and mood. 

While NSAIDs are widely available and typically covered by insurance, cannabis may involve higher treatment costs, particularly when accessed through private clinics. However, patients who don’t tolerate NSAIDs well often report meaningful relief with cannabis. Some even pursue combined therapy, using both in careful rotation to minimise reliance on either alone. 

Comparing Key Aspects 

Effectiveness 

NSAIDs are fast-acting for inflammation. Cannabis offers wider support for sleep, pain, and mental health. 

Side effects 

NSAIDs can cause gastrointestinal or cardiovascular issues. Cannabis may cause drowsiness or anxiety in some users. 

Accessibility and cost 

While NSAIDs are available through the NHS, treatment costs for cannabis are typically out-of-pocket. 

Combining therapies 

A growing number of patients report success with combined therapy, balancing the strengths of each option. 

Visit providers like LeafEase to explore whether cannabis vs NSAIDs, or a personalised mix of both, is best for managing your AS symptoms. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.